Get the latest tech news
Post-polio immune therapy aces human trials
Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced positive results.
Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors years after the initial infection and be very debilitating, have produced positive results. IVIG involves injecting a concentrated solution of antibodies into a vein to boost the recipient’s immune system’s ability to fight infections and reduce inflammation. “These results show a meaningful physical accomplishment, providing patients with more freedom of movement and the ability to be more self-reliant,” said Dr Jörg Schüttrumpf, Grifols Chief Scientific Innovation Officer.
Or read this on r/tech
